Received Jul 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | — |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 2 | — | — |
HCP reporting missed dose for GARDASIL-9. A 32-year-old patient had 2 doses of GARDASIL-9 when they were 17 years old and has not had their final dose. HCP did not provide any other information as they rushed to end the call. No additional AE/No PQC.; This spontaneous report was received from an other health professional and refers to a 32-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates (reported as when the patient was 17 years old), the patient was vaccinated with 2 doses of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (strength, dose, route of administration, lot # and expiration date were not reported) as prophylaxis and had not had the final dose (Inappropriate schedule of product administration). Additional information is not expected.